Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis
Graziella Filippini(Oldham Council), Georgia Salanti(University of Bern), Federico Piazza(Ospedale San Luigi Gonzaga), Omid Beiki(Karolinska Institutet), Cinzia Del Giovane(University of Modena and Reggio Emilia), Marinella Clerico(Ospedale San Luigi Gonzaga), Antonio Scalfari(Imperial College London), S. Fredrikson(Karolinska Institutet), Miriam Mattoscio(Imperial College London), Irene Tramacere(Fondazione IRCCS Istituto Neurologico Carlo Besta)
Cited by 48
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
|The Lancet|2013|2.5k
Graphical Tools for Network Meta-Analysis in STATA
|PLoS ONE|2013|2.5k